Edesa Biotech (EDSA) Times Interest Earned (2014 - 2026)
Edesa Biotech (EDSA) posted Times Interest Earned of -$23.14 for Q4 2025, down 22.99% sequentially from -$18.82 in Q2 2025, and down 23.32% YoY from -$30.18 in Q4 2024.
Edesa Biotech (EDSA) Times Interest Earned (2014 - 2026) Analysis & Trends
Edesa Biotech has reported Times Interest Earned for 12 years, with the latest figure at -$23.14 in Q4 2025.
- Quarterly Times Interest Earned fell 23.32% year-over-year to -$23.14 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$82.57 (down 18.4% YoY) and the FY2025 annual result came in at -$5.38, down 1285.01% from the prior year.
- Times Interest Earned slipped to -$23.14 in Q4 2025 per EDSA's latest filing, from -$18.82 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.19 in Q3 2022 and troughed at -$51.02 in Q4 2021.
- A 5-year average of -$11.61 and a median of -$3.09 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2021 and 2023: Times Interest Earned soared 97.61% in 2021, then tumbled 15817.05% in 2023.
- Over 5 years, Times Interest Earned stood at -$51.02 in 2021, then surged by 97.37% to -$1.34 in 2022, then increased by 17.18% to -$1.11 in 2023, then sank by 1591.52% to -$18.77 in 2024, then fell by 23.32% to -$23.14 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$23.14, -$18.82, and -$16.2 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Edesa Biotech | 40.44 Mn | 40.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.84 |
| Dec 31, 2025 | -23.14 |
| Jun 30, 2025 | -18.82 |
| Mar 31, 2025 | -16.20 |
| Dec 31, 2024 | -18.77 |
| Sep 30, 2024 | -12.88 |
| Jun 30, 2024 | -19.10 |
| Mar 31, 2024 | -1.33 |
| Dec 31, 2023 | -1.11 |
| Sep 30, 2023 | -29.91 |
| Jun 30, 2023 | -16.85 |
| Mar 31, 2023 | -1.36 |
| Dec 31, 2022 | -1.34 |
| Sep 30, 2022 | -0.19 |
| Jun 30, 2022 | -3.09 |
| Mar 31, 2022 | -1.00 |
| Dec 31, 2021 | -51.02 |
| Sep 30, 2021 | -0.47 |
| Jun 30, 2021 | -3.07 |
| Mar 31, 2021 | -1.00 |